Josh Mandel-Brehm - Chief Executive Officer, Director at Camp4 Therapeutics Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
CAMP on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Josh Mandel-Brehm since 12/23/2023

Holdings reported by Josh Mandel-Brehm for Camp4 Therapeutics Corp

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 272K Oct 15, 2024 Direct
Series B Preferred Stock 0 Oct 15, 2024 Direct Common Stock

Transactions reported by Josh Mandel-Brehm for Camp4 Therapeutics Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.